Serum Galectin‐1, Galectin‐9, and YKL‐40 levels in bipolar disorder and their relationship with cognitive functions
Open Access
- 12 February 2024
- journal article
- research article
- Published by Wiley in Brain and Behavior
- Vol. 14 (2) , e3421
Abstract
Purpose: The number of studies conducted on the role of neuroinflammation in the etiopathogenesis of bipolar disorder has been increasing in recent years. The role of Galectin‐1, Galectin‐9, and YKL‐40, which are considered to play roles in neuroinflammation and the etiopathogenesis of bipolar disorder, and the relationship of these parameters with cognitive functions were investigated in the present study.Method: Serum Galectin‐1, Galectin‐9, and YKL‐40 levels were measured with the ELISA Method in 64 bipolar euthymic patients and 64 healthy controls. The Stroop and trail‐making tests were administered to assess cognitive functions in all participants.Results: Serum Galectin‐1, Galectin‐9, and YKL‐40 levels were statistically and significantly lower in the patient group when compared to the healthy control group. The scores of the Stroop test and trail‐making tests were statistically higher in the patient group than in the healthy control group. There was a weak and positive correlation between serum Galectin‐1, Galectin‐9, and YKL‐40 levels and cognitive performance in all participants.Discussion and conclusion: Statistically significant low levels of serum Galectin‐1, Galectin‐9, and YKL‐40 detected in the patient group suggest that these parameters have important roles in neuroinflammation. The statistically higher Stroop and trail‐making test scores of the patient group compared to the control group indicates that the cognitive performance of the patient group was weaker. Also, the positive correlation between Galectin‐1, Galectin‐9, and YKL‐40 levels and cognitive performance suggests that these molecules may have a neuroprotective role. We think that the present study will contribute to this field where there is very limited data in the literature.Keywords
This publication has 38 references indexed in Scilit:
- Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar DisorderAmerican Journal of Psychiatry, 2004
- Transcriptional Regulation of CHI3L1, a Marker Gene for Late Stages of Macrophage DifferentiationJournal of Biological Chemistry, 2003
- Proteomic analysis of the reactive phenotype of astrocytes following endothelin‐1 exposureProteomics, 2003
- Decreased galectin-1 immunoreactivity of the skin in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 2003
- Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?Trends in Immunology, 2002
- Expression of galectins in cancer: A critical reviewGlycoconjugate Journal, 2002
- Gene expression differences in bipolar disorder revealed by cDNA array analysis of post‐mortem frontal cortexJournal of Neurochemistry, 2001
- Cognitive Impairment in Euthymic Bipolar Patients With and Without Prior Alcohol DependenceArchives of General Psychiatry, 1998
- Identification of proteins secreted by human osteoblastic cells in cultureJournal of Bone and Mineral Research, 1992
- A biochemical basis for the actions of lithium on behaviour and on immunity: Relapsing and remitting disorders of inflammation and immunity such as multiple sclerosis or recurrent herpes as manic-depression of the immune systemMedical Hypotheses, 1981